Literature DB >> 1849333

Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS.

G L Stoner1.   

Abstract

JCV infects oligodendrocytes and, to a lesser extent, astrocytes in the brain and spinal cord and causes the demyelinating disease known as progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals. The possibility exists that this opportunistic infection reactivates from a latent state in the brain. It is proposed that the pathogenetic immune response in a multiple sclerosis (MS) brain may be directed predominantly toward antigens of a DNA virus, such as JCV, which is latent in glial cells. The target antigens could be synthesized only during transient viral reactivation or could persist, thus explaining the two basic patterns of neurological symptoms in MS. It is further proposed that the viral genome as a minichromosome becomes focally distributed in glial cells following vertical passage in dividing progenitor cells after infection early in life. The concept that the host response to a single agent can evoke two distinct pathologies (PML and MS) derives from a chronic mycobacterial infection of peripheral nerves-leprosy.

Entities:  

Mesh:

Year:  1991        PMID: 1849333

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 2.  Progressive multifocal leucoencephalopathy.

Authors:  N J Dalsgaard Hansen; C Madsen; E Stenager
Journal:  Ital J Neurol Sci       Date:  1996-12

3.  Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.

Authors:  Jennifer L McGuire; Vera Fridman; Christian Wüthrich; Igor J Koralnik; Dina Jacobs
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

4.  JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 5.  The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors.

Authors:  M P Berleur; S Cordier
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

Review 6.  The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?

Authors:  Jens Geginat; Moira Paroni; Massimiliano Pagani; Daniela Galimberti; Raffaele De Francesco; Elio Scarpini; Sergio Abrignani
Journal:  Trends Immunol       Date:  2017-05-23       Impact factor: 16.687

Review 7.  Viruses, virulence and pathogenicity.

Authors:  J Hibbs; N S Young
Journal:  Baillieres Clin Haematol       Date:  1995-03

Review 8.  Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

Authors:  G L Stoner
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

9.  Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches.

Authors:  Anna Onisiforou; George M Spyrou
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.